Tetraalkynylated and Tetraalkenylated Benzenes and Pyridines
1744 (w), 1490 (m), 1413 (m), 1260 (w), 1066 (w), 908 (m),
745 (s), 680 (s), 528 cmÀ1 (s); MS (EI, 70 eV): m/z (%)=479
(M+, 100), 450 (4), 401 (7), 350 (3), 238 (18), 226 (20); HR-
MS (ESI): m/z=480.17455, calcd. for [M+H]+ C37H22N:
480.17468.
2,3,5,6-Tetrakis-[(4-methoxyphenyl)ethynyl]pyridine (2b):
According to the general procedure compound 2b was iso-
lated as a yellow solid; yield: 277 mg (93%); mp 202–2048C.
1H NMR (300 MHz, CDCl3): d=3.73, 3.75 (s, 12H, OMe),
6.76–6.83 (m, 8H, CH), 7.39–7.51 (m, 8H, CH), 7.82 (s, 1H,
CHPyr); 13C NMR (75 MHz, CDCl3): d=55.3 (OMe), 77.2,
171–1738C. 1H NMR (300 MHz, CDCl3): d=0.86 (t, 12H,
3
3J=7.3 Hz, CH3), 1.30 (sext, 8H, J=7.3 Hz, CH2), 1.54–1.65
3
(m, 8H, CH2), 2.81 (t, 4H, J=7.4 Hz, CH2), 2.82 (t, 4H,
3
3J=7.3 Hz. CH2), 7.44 (d, 4H, J=8.7 Hz, CH), 7.50 (d, 4H,
3J=8.6 Hz, CH), 7.7–7.80 (m, 8H, CH); 13C NMR (75 MHz,
CDCl3): d=13.8 (CH3), 22.3 (CH2), 26.1 (CH2), 38.3 (CH2),
ꢀ
87.7, 89.8, 94.2, 97.2 (C C), 121.4 (CPyr), 126.0, 126.3 (CAr),
127.9, 128.0, 131.7, 132.1 (CH), 136.8, 137.0 (CAr), 141.2
(CHPyr), 143.3 (CPyr), 199.1, 199.1 (C=O); IR (ATR): n=
2953 (m), 2930 (m), 2867 (m), 2204 (w), 1682 (s), 1598 (s),
1554 (w), 1413 (s), 1343 (m), 1251 (m), 1202 (s), 1109 (m),
969 (m), 853 cmÀ1 (m); MS (EI, 70 eV): m/z (%)=815 (M+,
3), 457 (33), 289 (5), 207 (12), 169 (22), 154 (31); HR-MS
(ESI): m/z=816.40363, calcd. for [M+H]+ C57H54N1O4:
816.40474; anal. calcd. for C57H53NO4 (816.04): C 83.89, H
6.55, N 1.72; found: C 83.79, H 6.428, N 1.827.
ꢀ
84.5, 86.7, 97.7 (C C), 114.1, 114.2 (CH), 114.6, 121.2,
(CAr/Hetar), 133.3, 133.9 (CH), 140.8 (CHPyr), 142.9 (CHetar),
160.3, 160.5 (CAr); IR (ATR): n=2932 (w), 2835 (w), 2200
(m), 1602 (m), 1508 (s), 1292 (m), 1245 (s), 1024 (m), 923
(w), 826 (s), 532 (s). MS (EI, 70 eV): m/z (%)=599 (M+,
100), 584 (4), 426 (1), 329 (4), 300 (4), 213 cmÀ1 (2); HR-MS
(EI, 70 eV): m/z=599.20907, calcd. for C41H29NO4:
599.20911.
2,3,5,6-Tetrakis[(4-pentylphenyl)ethynyl]pyridine
(2g):
According to the general procedure compound 2g was iso-
lated as a brown solid; yield: 323 mg (85%); mp 99–1008C.
1H NMR (300 MHz, CDCl3): d=0.82 (t, 12H, 3J=6.3 Hz,
CH3), 1.16–1.30 (m, 16H, CH2), 1.49–1.60 (m, 8H, CH2),
2,3,5,6-Tetrakis((4-tert-butylphenyl)ethynyl)pyridine (2c):
According to the general procedure compound 2c was iso-
lated as an orange solid; yield: 271 mg (77%); mp 276–
3
2.51–2.57 (m, 8H, CH2), 7.08 (d, 4H, J=8.1 Hz, CH), 7.10
1
3
3
2788C. H NMR (300 MHz, CDCl3): d=1.25, 1.26 (s, 36H,
(d, 4H, J=8.1 Hz, CH), 7.41 (d, 4H, J=8.1 Hz, CH), 7.47
(d, 4H, 3J=8.1 Hz, CH); 13C NMR (75 MHz, CDCl3): d=
14.0 (CH3), 22.5, 30.8, 30.8, 31.4, 35.9, 36.0 (CH2), 85.1, 87.4,
CH3), 7.28–7.33 (m, 8H, CH), 7.43–7.51 (m, 8H, CH), 7.88
(s, 1H, CH); 13C NMR (75 MHz, CDCl3): d=31.1 (CH3),
ꢀ
ꢀ
34.9 (Ct-Bu), 85.1, 87.3, 95.3, 97.7 (C C), 119.2, 119.5, 121.4
95.3, 97.8 (C C), 119.4, 119.7, 121.4 (CAr/HetAr), 128.5, 128.6,
(CAr/Hetar), 125.4, 125.5, 131.5, 132.0 (CH), 141.1 (CHPyr),
143.4, 152.5, 152.7 (CAr/Hetar); IR (ATR): n=2957 (m), 2903
(w), 2865 (w), 2204 (m), 1604 (w), 1504 (m), 1416 (m), 1362
(m), 1266 (m), 1104 (m), 1016 (w), 829 cmÀ1 (s); MS (EI,
70 eV): m/z (%)=703 (M+, 100), 688 (13), 632 (5), 616 (4),
560 (3), 337 (7), 119 (2); HR-MS (ESI): m/z=704.42574,
calcd. for [M+H]+ C53H54N: 704.42508.
131.7, 132.2 (CH), 140.8 (CHPyr), 143.5, 144.4, 144.6
(CAr/Hetar). IR (ATR): n=2955 (m), 2926 (s), 2854 (s), 2207
(m), 1908 (w), 1605 (w), 1510 (s), 1465 (m), 1414 (s), 1263
(w), 1223 (w), 1158 (m), 1115 (m), 1018 (m), 911 (s), 827 (s),
729 cmÀ1 (s); MS (EI, 70 eV): m/z (%)=759 (M+, 100), 702
(3), 646 (12), 546 (3), 380 (4), 267 (6); HR-MS (ESI): m/z=
760.48643, calcd. for [M+H]+ C57H62N: 760.48768.
2,3,5,6-Tetrakis-[(4-fluorophenyl)ethynyl]pyridine
(2d):
2,3,5,6-Tetrakis[(triisopropylsilyl)ethynyl]pyridine
(2h):
According to the general procedure compound 2d was iso-
lated as a yellow solid; yield: 178 mg (65%); mp 2708C.
1H NMR (300 MHz, CDCl3): d=7.04–7.12 (m, 8H, CH),
7.53–7.62 (m, 8H, CH); 13C NMR (75 MHz, CDCl3): due to
the low solubility measurement of a 13C NMR-experiment
was impossible; IR (ATR): n=3060 (w), 2225 (w), 2209 (m),
1600 (m), 1505 (s), 11416 (m), 1219 (s), 1152 (s), 1016 (w),
909 (w), 828 (s), 767 (m), 526 cmÀ1 (s); MS (EI, 70 eV): m/z
(%)=551 (M+, 100), 530 (3), 455 (3), 404 (2), 276 (5), 262
(13); HR-MS (ESI): m/z=552.13752, calcd. for [M+H]+
C37H18F4N: 552.13699; anal. calcd. for C37H17F4N (551.53): C
80.57, H 3.11, N 2.54; found: C 79.92, H 2.982, N 2.753.
2,3,5,6-Tetrakis-(p-tolylethynyl)pyridine (2e): According
to the general procedure compound 2e was isolated as an
orange solid; yield: 183 mg (69%); mp 2798C. 1H NMR
(300 MHz, CDCl3): d=2.28, 2.29 (s, 12H, CH3), 7.06–7.10
(m, 8H, CH), 7.36–7.46 (m, 8H, CH), 7.85 (s, 1H, CHPyr);
13C NMR (75 MHz, CDCl3): d=21.6, 21.6 (CH3), 85.0, 87.3,
According to the general procedure compound 2h was iso-
lated as a yellowish solid; yield: 337 mg (85%); mp 2378C.
1H NMR (300 MHz, CDCl3): d=1.00–1.07 (m, 84H, CH,
CH3), 7.63 (s, 1H, CH); 13C NMR (75 MHz, CDCl3): d=
11.3, 11.4 (CH), 18.7, 18.7 (CH3), 97.6, 100.5, 102.3, 104.2
(C< =3>C), 121.0 (CPyr), 142.7 (CH), 144.8 (CPyr); IR
(ATR): n=2942 (s), 2890 (m), 2864 (s), 2148 (w), 1461 (m),
1404 (s), 1226 (w), 1175 (w), 11072 (w), 996 (m), 919 (m),
880 (s), 773 (m), 676 (s), 659 cmÀ1 (s); MS (EI, 70 eV): m/z
(%)=800 (M+, 11), 756 (79), 714 (100), 686 (4), 672 (3), 630
(2); HR-MS (ESI): m/z=800.58267, calcd. for [M+H]+
C49H86NSi4: 800.58318.
2,3,5,6-Tetrakis(hex-1-ynyl)pyridine (2i): According to the
general procedure compound 2i was isolated as a brown oil;
1
yield: 122 mg (62%). H NMR (300 MHz, CDCl3): d=0.82
(t, 6H, 3J=7.0 Hz, CH3), 0.84 (t, 6H, 3J=7.2 Hz, CH3),
3
1.33–1.55 (m, 16H, CH2), 3.35 (t, 4H, J=6.8 Hz, CH2), 2.36
(t, 4H, 3J=6.9 Hz, CH2), 7.51 (s, 1H, CH); 13C NMR
(75 MHz, CDCl3): d=13.6 (CH3), 19.3, 19.4, 21.9, 22.0, 30.3,
ꢀ
95.4, 97.8 (C C), 119.1, 119.4, 121.4 (CAr/HetAr), 129.2, 129.3,
ꢀ
131.6, 132.1 (CH), 139.4, 139.7 (CAr/HetAr), 140.9 (CHPyr); IR
(ATR): n=2199 (w), 1508 (w), 1409 (w), 1040 (s), 969 (w),
806 (m), 527 (m), 441 (s). MS (EI, 70 eV): m/z (%)=535
(M+, 100), 520 (4), 504 (8), 489 (1), 268 (2), 252 cmÀ1 (4);
HR-MS (ESI): m/z=536.23679, calcd. for [M+H]+
C41H30N: 536.23728.
30.5 (CH2), 76.9, 79.2, 96.0, 98.1 (C C), 121.2 (CPyr), 141.6
(CH), 143.2 (CPyr); IR (ATR): n=2956 (m), 2930 (m), 2870
(m), 2229 (m), 1498 (w), 1416 (s), 1322 (w), 1200 (w), 1105
(s), 915 (m), 774 cmÀ1 (m); MS (EI, 70 eV): m/z (%)=399
(M+, 100), 370 (24), 356 (48), 342 (23), 328 (18), 315 (11),
284 (9); HR-MS (EI, 70 eV): m/z=399.29209, calcd. for
C29H37N: 399.29205.
2,3,5,6-Tetrakis(4-(pentan-1-one)phenylethynyl)pyridine
(2f): According to the general procedure compound 2f was
isolated as a yellow-brown solid; yield: 209 mg (52%); mp
1,2,4,5-Tetrakis(phenylethynyl)benzene (4a): According to
the general procedure compound 4a was isolated as an
Adv. Synth. Catal. 0000, 000, 0 – 0
ꢂ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7
ÞÞ
These are not the final page numbers!